![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
EL Barker and RD Blakely
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6600, USA.
When assayed in parallel using transfected mammalian cells, human and rat serotonin transporters (SERTs) exhibit consistent differences in potency for tricyclic antidepressants but not for 5-hydroxytryptamine, cocaine, or nontricyclic serotonin transporter-selective reuptake inhibitors. Previously, using chimeric proteins, we determined that domains or residues distal to transmembrane domain 11 (amino acid 531) dictate the increased sensitivity of human SERT to imipramine. Using an additional chimera and site-directed mutagenesis, we have determined that a single amino acid, F586, is responsible for increased sensitivity to imipramine, desipramine, and nortriptyline. Thus, mutation of wild-type rat SERT (V586) to the human SERT identity F586, but no other divergent amino acids between human and rat SERTs, selectively increased tricyclic antidepressant potency. A reciprocal reduction in potency was observed when human SERT F586 was converted to the cognate rat SERT residue (V586). Interactions with other SERT antagonists, including paroxetine and cocaine, as well as the SERT substrates 5-hydroxytryptamine and d-amphetamine were unaffected by interconversion of this residue. Phenylalanine conversion in the human norepinephrine transporter at the homologous position failed to alter tricyclic inhibition of catecholamine uptake, revealing a SERT-specific context for use of the aromatic side chain at this position. Additional constraints on aromaticity at rat SERT position 586 were revealed by conversion of rat SERT V586 to Y586, which failed to repllcate the effect of the F586 mutation. In addition, conversion to V586D, but not V586R, increased tricyclic potency to that of human SERT and additionally increased potency for cocaine but not paroxetine. These results implicate distal domains and a single residue in TMD 12 in the formation of high affinity SERT antagonist binding sites.
This article has been cited by other articles:
|
|
 |
|
  L. van den Berg, L. Kwant, M. S. Hestand, B. A. van Oost, and P. A. J. Leegwater Structure and Variation of Three Canine Genes Involved in Serotonin Binding and Transport: The Serotonin Receptor 1A Gene (htr1A), Serotonin Receptor 2A Gene (htr2A), and Serotonin Transporter Gene (slc6A4) J. Hered., November 1, 2005; 96(7): 786 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Hahn, M. S. Mazei-Robison, and R. D. Blakely Single Nucleotide Polymorphisms in the Human Norepinephrine Transporter Gene Affect Expression, Trafficking, Antidepressant Interaction, and Protein Kinase C Regulation Mol. Pharmacol., August 1, 2005; 68(2): 457 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Larsen, B. Elfving, and O. Wiborg The Chicken Serotonin Transporter Discriminates between Serotonin-selective Reuptake Inhibitors: A SPECIES-SCANNING MUTAGENESIS STUDY J. Biol. Chem., October 1, 2004; 279(40): 42147 - 42156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Kilic, D. L. Murphy, and G. Rudnick A Human Serotonin Transporter Mutation Causes Constitutive Activation of Transport Activity Mol. Pharmacol., August 1, 2003; 64(2): 440 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Adkins, E. L. Barker, and R. D. Blakely Interactions of Tryptamine Derivatives with Serotonin Transporter Species Variants Implicate Transmembrane Domain I in Substrate Recognition Mol. Pharmacol., March 1, 2001; 59(3): 514 - 523. [Abstract] [Full Text]
|
|
|
|
|
|
G. Xiao, J. Wang, T. Tangen, and K. M. Giacomini A Novel Proton-Dependent Nucleoside Transporter, CeCNT3, from Caenorhabditis elegans Mol. Pharmacol., February 1, 2001; 59(2): 339 - 348. [Abstract] [Full Text]
|
|
|
|
|
|
P. Pörzgen, S. K. Park, J. Hirsh, M. S. Sonders, and S. G. Amara The Antidepressant-Sensitive Dopamine Transporter in Drosophila melanogaster: A Primordial Carrier for Catecholamines Mol. Pharmacol., January 1, 2001; 59(1): 83 - 95. [Abstract] [Full Text]
|
|
|
|
|
|
C. J. Loland, L. Norregaard, and U. Gether Defining Proximity Relationships in the Tertiary Structure of the Dopamine Transporter. IDENTIFICATION OF A CONSERVED GLUTAMIC ACID AS A THIRD COORDINATE IN THE ENDOGENOUS Zn2+-BINDING SITE J. Biol. Chem., December 24, 1999; 274(52): 36928 - 36934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Barker, K. R. Moore, F. Rakhshan, and R. D. Blakely Transmembrane Domain I Contributes to the Permeation Pathway for Serotonin and Ions in the Serotonin Transporter J. Neurosci., June 15, 1999; 19(12): 4705 - 4717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Y. Penado, G. Rudnick, and M. M. Stephan Critical Amino Acid Residues in Transmembrane Span 7 of the Serotonin Transporter Identified by Random Mutagenesis J. Biol. Chem., October 23, 1998; 273(43): 28098 - 28106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-X. Chen, H. Pan, T. P. Rothman, P. R. Wade, and M. D. Gershon Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception Am J Physiol Gastrointest Liver Physiol, September 1, 1998; 275(3): G433 - G448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Barker, M. A. Perlman, E. M. Adkins, W. J. Houlihan, Z. B. Pristupa, H. B. Niznik, and R. D. Blakely High Affinity Recognition of Serotonin Transporter Antagonists Defined by Species-scanning Mutagenesis. AN AROMATIC RESIDUE IN TRANSMEMBRANE DOMAIN I DICTATES SPECIES-SELECTIVE RECOGNITION OF CITALOPRAM AND MAZINDOL J. Biol. Chem., July 31, 1998; 273(31): 19459 - 19468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Owens, W. N. Morgan, S. J. Plott, and C. B. Nemeroff Neurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1305 - 1322. [Abstract] [Full Text]
|
|
|
|
|
|
J.-G. Chen, A. Sachpatzidis, and G. Rudnick The Third Transmembrane Domain of the Serotonin Transporter Contains Residues Associated with Substrate and Cocaine Binding J. Biol. Chem., November 7, 1997; 272(45): 28321 - 28327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kamdar, K. M. Y. Penado, G. Rudnick, and M. M. Stephan Functional Role of Critical Stripe Residues in Transmembrane Span 7 of the Serotonin Transporter. EFFECTS OF Na+, Li+, AND METHANETHIOSULFONATE REAGENTS J. Biol. Chem., February 2, 2001; 276(6): 4038 - 4045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Roubert, P. J. Cox, M. Bruss, M. Hamon, H. Bonisch, and B. Giros Determination of Residues in the Norepinephrine Transporter That Are Critical for Tricyclic Antidepressant Affinity J. Biol. Chem., March 9, 2001; 276(11): 8254 - 8260. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
